138 related articles for article (PubMed ID: 6371282)
1. Effect of prostacyclin and prazosin in the treatment of congestive heart failure; with special reference to the sympathetic nervous system.
Yui Y; Sakurai T; Nakajima H; Kawai C
Jpn Circ J; 1984 Apr; 48(4):365-72. PubMed ID: 6371282
[TBL] [Abstract][Full Text] [Related]
2. Prostacyclin therapy in patients with congestive heart failure.
Yui Y; Nakajima H; Kawai C; Murakami T
Am J Cardiol; 1982 Aug; 50(2):320-4. PubMed ID: 7048886
[TBL] [Abstract][Full Text] [Related]
3. Sustained effectiveness of chronic prazosin therapy in severe chronic congestive heart failure.
Bertel O; Burkart F; Bühler FR
Am Heart J; 1981 May; 101(5):529-33. PubMed ID: 7223592
[TBL] [Abstract][Full Text] [Related]
4. The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril).
Kluger J; Cody RJ; Laragh JH
Am J Cardiol; 1982 May; 49(7):1667-74. PubMed ID: 7044087
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of prazosin effect on cardiac output in chronic heart failure.
Arnold SB; Williams RL; Ports TA; Baughman RA; Benet LZ; Parmley WW; Chatterjee K
Ann Intern Med; 1979 Sep; 91(3):345-9. PubMed ID: 475164
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, hemodynamics and echocardiography.
Awan NA; Miller RR; DeMaria AN; Maxwell KS; Neumann A; Mason DT
Circulation; 1977 Sep; 56(3):346-54. PubMed ID: 884789
[TBL] [Abstract][Full Text] [Related]
7. Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator prazosin.
Miller RR; Awan NA; Maxwell KS; Mason DT
N Engl J Med; 1977 Aug; 297(6):303-7. PubMed ID: 889599
[TBL] [Abstract][Full Text] [Related]
8. Development of pharmacodynamic tolerance to prozosin in congestive heart failure.
Desch CE; Magorien RD; Triffon DW; Blanford MF; Unverferth DV; Leier CV
Am J Cardiol; 1979 Nov; 44(6):1178-82. PubMed ID: 495512
[TBL] [Abstract][Full Text] [Related]
9. Differences in hemodynamic effects of nitroprusside and prazosin in severe chronic congestive heart failure: evidence for a direct negative chronotropic effect of prazosin.
Packer M; Meller J; Gorlin R; Herman MV
Am J Cardiol; 1979 Aug; 44(2):310-7. PubMed ID: 463769
[TBL] [Abstract][Full Text] [Related]
10. The acute and chronic haemodynamic effects of prazosin in severe congestive cardiac failure.
Harper RW; Claxton H; Middlebrook K; Anderson S; Pitt A
Med J Aust; 1980 Jul; 2(SP1):36-8. PubMed ID: 7421721
[No Abstract] [Full Text] [Related]
11. Prazosin in the treatment of severe chronic congestive cardiac failure.
Hockings BE; Cope GD; Clarke GM; Taylor RR
Aust N Z J Med; 1980 Aug; 10(4):420-5. PubMed ID: 6932833
[TBL] [Abstract][Full Text] [Related]
12. A comparison of prostacyclin and sodium nitroprusside for the treatment of heart failure after cardiac surgery.
Kieler-Jensen N; Houltz E; Ricksten SE
J Cardiothorac Vasc Anesth; 1995 Dec; 9(6):641-6. PubMed ID: 8664453
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic and neurohumoral effects of long-term prostaglandin E1 infusions in outpatients with severe congestive heart failure.
Hülsmann M; Stanek B; Frey B; Berger R; Rödler S; Siegel A; Hartter E; Schuller M; Ogris E; Pacher R
J Heart Lung Transplant; 1997 May; 16(5):556-62. PubMed ID: 9171275
[TBL] [Abstract][Full Text] [Related]
14. Increase in plasma norepinephrine during prazosin therapy for chronic congestive heart failure.
Stein L; Henry DP; Weinberger MH
Am J Med; 1981 Apr; 70(4):825-32. PubMed ID: 7011023
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic application of prazosin in chronic refractory congestive heart failure. Tolerance and "tachyphylaxis" in perspective.
Awan NA; Needham KE; Evenson MK; Amsterdam EE; Mason DT
Am J Med; 1981 Jul; 71(1):153-60. PubMed ID: 7246573
[TBL] [Abstract][Full Text] [Related]
16. Beneficial hemodynamic response to chronic prazosin therapy in congestive heart failure.
Feldman RC; Ball RM; Winchester MA; Jaillon P; Kates RE; Harrison DC
Am Heart J; 1981 May; 101(5):534-40. PubMed ID: 7223593
[TBL] [Abstract][Full Text] [Related]
17. Acute hemodynamic and long-term clinical effects of prazosin in the treatment of chronic congestive heart failure.
von der Lippe G; Ohm OJ; Lund-Johansen P
Acta Med Scand; 1981; 210(3):213-6. PubMed ID: 7293839
[TBL] [Abstract][Full Text] [Related]
18. Increased plasma norepinephrine levels during prazosin therapy for severe congestive heart failure.
Colucci WS; Williams GH; Braunwald E
Ann Intern Med; 1980 Sep; 93(3):452-3. PubMed ID: 7436166
[TBL] [Abstract][Full Text] [Related]
19. Additive haemodynamic effects of piroximone and prostacyclin in severe chronic heart failure.
Albo C; Saal JP; Lellouche D; Habbal R; Benvenuti C; Deleuze P; Loisance D; Castaigne A; Dubois-Randé JL
Eur Heart J; 1994 Apr; 15(4):528-33. PubMed ID: 8070481
[TBL] [Abstract][Full Text] [Related]
20. Acute haemodynamic effects of oral prazosin in severe mitral regurgitation.
Mehta J; Feldman RL; Nichols WW; Pepine CJ; Conti CR
Br Heart J; 1980 May; 43(5):556-60. PubMed ID: 7378216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
